Tonix Pharmaceuticals Holding TNXP Earnings Call Transcripts

NASDAQ TNXP
$4.10 -0.39 (-8.69%)
At close: Nov 10, 2026 · 4:00 PM EST
1 earnings call on file for Tonix Pharmaceuticals Holding, Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Tonix Pharmaceuticals Holding Q2 2026 Earnings Call

Aug 10, 2026 5,282 words · 23 min read
  • Deborah ElsonHead of Investor Relations
  • Seth LedermanChief Executive Officer
  • Thomas EngleseExecutive Vice President of Commercial Operations
  • Bradley SaengerChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Tonix Pharmaceuticals Holding Earnings Call Transcripts

Calls1
LatestAug 10, 2026
SinceQ2 2026

Fiscal 2026

All 1 Tonix Pharmaceuticals Holding transcript Register to get access to Tonix Pharmaceuticals Holding’s earnings call transcripts.